Revenue grew 1.8% year-over-year to €629.8 million, with net profit up 2.2% to €71.3 million, driven by volume growth across all regions and strong gains in Pet treats and Health. EBITDA margin declined due to higher costs, but price and cost actions are supporting guidance.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.